login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Medindia »
Consumer Health »
Health Information »
Latest Publication and Research on Cystic Fibrosis
| Disease Info Index | ||||||||||||||||||||||||||
|
|
Cystic Fibrosis
Page Options
Drugs For Cystic Fibrosis
amikacin
azithromycin
aztreonam
ceftazidime
doxercalciferol
ethinyl estradiol and levonorgestrel
gentamicin
ibuprofen
ivacaftor
pancrelipase
tobramycin
vitamin e
Cystic Fibrosis - Symptoms - CFTR mutation - Diagnosis - Treatment - Prognosis
Latest Publication and Research on Cystic Fibrosis
|
|
|
Text 
|
Gastroenterol Res Pract Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients. Pohl JF, Patel R, Zobell JT, Lin E, Korgenski EK, Crowell K, Mackay MW, Richman A, Larsen C, Chatfield BA Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84113-1103, USA. Children with cystic fibrosis (CF) often take proton pump inhibitors (PPIs), which helps improve efficacy of fat absorption with pancreatic enzyme rep... Read More Source: PubMed 2011 Dec 5 VAMP8 is a vesicle SNARE that regulates mucin secretion in airway goblet cells. Jones LC, Moussa L, Fulcher LM, Zhu Y, Hudson EJ, O'Neal WK, Randell SH, Lazarowski ER, Boucher RC, Kreda SM University of North Carolina; Mucin secretion is an innate defence mechanism, which is noxiously upregulated in obstructive lung diseases (e.g., COPD, cystic fibrosis, asthma). Mu... Read More Source: PubMed Exp Clin Transplant Bilateral lung transplant for bronchiectasis in asymmetric thorax: a case report. Wang Y, Chen J, Wei D, Zheng M, Zhang J, Wu B From the Wuxi People's Hospital, Department of Thoracic Transplant, Wuxi, China. Patients with suppurative lung diseases such as bronchiectasis and cystic fibrosis can be treated surgically, which leads to an asymmetric thorax, mak... Read More Source: PubMed Exp Clin Transplant Bilateral lung transplant for bronchiectasis in asymmetric thorax: a case report. Wang Y, Chen J, Wei D, Zheng M, Zhang J, Wu B From the Wuxi People's Hospital, Department of Thoracic Transplant, Wuxi, China. Patients with suppurative lung diseases such as bronchiectasis and cystic fibrosis can be treated surgically, which leads to an asymmetric thorax, mak... Read More Source: PubMed 2011 Dec 3 Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M Department of Pediatrics, Gastroenterology and Allergology, Medical University of Bialystok, Bialystok, Poland. Objectives: There is a need to replace liver biopsy with non-invasive markers that predict the degree of liver fibrosis in fatty liver disease related... Read More Source: PubMed 2011 Dec 3 Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M Department of Pediatrics, Gastroenterology and Allergology, Medical University of Bialystok, Bialystok, Poland. Objectives: There is a need to replace liver biopsy with non-invasive markers that predict the degree of liver fibrosis in fatty liver disease related... Read More Source: PubMed 2011 Dec 2 Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus. Hillman M, Eriksson L, Mared L, Helgesson K, Landin-Olsson M Department of Clinical Sciences, Biomedical Center, Lund University, Sweden. Glucagon like peptide 1 (GLP-1) is an incretin hormone released as a bioactive peptide from intestinal L-cells in response to eating. It acts on targe... Read More Source: PubMed 2011 Dec 2 Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus. Hillman M, Eriksson L, Mared L, Helgesson K, Landin-Olsson M Department of Clinical Sciences, Biomedical Center, Lund University, Sweden. Glucagon like peptide 1 (GLP-1) is an incretin hormone released as a bioactive peptide from intestinal L-cells in response to eating. It acts on targe... Read More Source: PubMed 2011 Dec 2 CFTR: folding, misfolding and correcting the ?F508 conformational defect. Lukacs GL, Verkman AS Department of Physiology and GRASP, McGill University, Montréal, Quebec H3E 1Y6, Canada. Cystic fibrosis (CF), the most common lethal genetic disease in the Caucasian population, is caused by loss-of-function mutations of the CF transmembr... Read More Source: PubMed 2011 Dec 2 CFTR: folding, misfolding and correcting the ?F508 conformational defect. Lukacs GL, Verkman AS Department of Physiology and GRASP, McGill University, Montréal, Quebec H3E 1Y6, Canada. Cystic fibrosis (CF), the most common lethal genetic disease in the Caucasian population, is caused by loss-of-function mutations of the CF transmembr... Read More Source: PubMed Gastroenterol Res Pract Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients. Pohl JF, Patel R, Zobell JT, Lin E, Korgenski EK, Crowell K, Mackay MW, Richman A, Larsen C, Chatfield BA Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84113-1103, USA. Children with cystic fibrosis (CF) often take proton pump inhibitors (PPIs), which helps improve efficacy of fat absorption with pancreatic enzyme rep... Read More Source: PubMed 2011 Dec 5 VAMP8 is a vesicle SNARE that regulates mucin secretion in airway goblet cells. Jones LC, Moussa L, Fulcher LM, Zhu Y, Hudson EJ, O'Neal WK, Randell SH, Lazarowski ER, Boucher RC, Kreda SM University of North Carolina; Mucin secretion is an innate defence mechanism, which is noxiously upregulated in obstructive lung diseases (e.g., COPD, cystic fibrosis, asthma). Mu... Read More Source: PubMed 2011 Dec 2 Measuring Children's Decision-Making Involvement Regarding Chronic Illness Management. Miller VA, Harris D Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania and Center for the Integration of Genetic Healthcare Technologies, Perelman School of Medicine at the University of Pennsylvania. OBJECTIVES: To develop a measure of decision-making involvement in children and adolescents with cystic fibrosis, diabetes, and asthma. METHODS: Pare... Read More Source: PubMed 2011 Dec 1 Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G, McKevitt M, Elborn JS, Tunney MM CF and Airways Microbiology Research Group, Queen's University Belfast, United Kingdom. BACKGROUND: There is a need for new antibiotics or combination of antibiotics that possess activity against increasingly resistant cystic fibrosis (CF... Read More Source: PubMed 2011 Dec 2 [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience.] Juan-Fita MJ, Egea-Mellado JM, González-Gallego I, Moya-Quiles MR, Fernández-Sánchez A Sección de Metabolopatías, Centro de Bioquímica y Genética Clínica, Hospital Universitario Virgen de la Arrixaca, Murcia, Espańa. BACKGROUND AND OBJECTIVE: The early detection of inborn errors of metabolism by mass spectrometry allows expanding the traditional neonatal screening ... Read More Source: PubMed 2011 Nov 28 Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. Loo TW, Bartlett MC, Shi L, Clarke DM Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada. The most common cause of cystic fibrosis is deletion of Phe508 in the first nucleotide-binding domain (NBD) of the CFTR chloride channel, which inhibi... Read More Source: PubMed 2011 Nov 28 Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. Loo TW, Bartlett MC, Shi L, Clarke DM Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada. The most common cause of cystic fibrosis is deletion of Phe508 in the first nucleotide-binding domain (NBD) of the CFTR chloride channel, which inhibi... Read More Source: PubMed 2011 Dec 2 Measuring Children's Decision-Making Involvement Regarding Chronic Illness Management. Miller VA, Harris D Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania and Center for the Integration of Genetic Healthcare Technologies, Perelman School of Medicine at the University of Pennsylvania. OBJECTIVES: To develop a measure of decision-making involvement in children and adolescents with cystic fibrosis, diabetes, and asthma. METHODS: Pare... Read More Source: PubMed 2011 Dec 1 Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G, McKevitt M, Elborn JS, Tunney MM CF and Airways Microbiology Research Group, Queen's University Belfast, United Kingdom. BACKGROUND: There is a need for new antibiotics or combination of antibiotics that possess activity against increasingly resistant cystic fibrosis (CF... Read More Source: PubMed 2011 Dec 2 [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience.] Juan-Fita MJ, Egea-Mellado JM, González-Gallego I, Moya-Quiles MR, Fernández-Sánchez A Sección de Metabolopatías, Centro de Bioquímica y Genética Clínica, Hospital Universitario Virgen de la Arrixaca, Murcia, Espańa. BACKGROUND AND OBJECTIVE: The early detection of inborn errors of metabolism by mass spectrometry allows expanding the traditional neonatal screening ... Read More Source: PubMed |
| Share it! |  |
 |
 |
 |
 |
 |
 |
|
|
Comment & Contribute
|
Posted by:
prema
Posted on: 12/20/2009 Cystic fibrosis in India is rare. Also there is less awareness among medical staff. Apparently frequency of common mutation F508del in Indian children is between 19% and 34%. The cystic fibrosis wordlwide is willing to fund projects for two years in India. There is an appeal on thier site - just google cystic fibrosis wordlwide india and see the response. |
| Citing this Health Article | ||||||
|
||||||
| News on Cystic Fibrosis |
|
Danger Detected in Standard Treatment for A Grave Lung Disease |
|
TB Raises Lung Cancer Mortality Risk in Elderly |
|
Prenatal Exposure to Polluted Air may Compromise Development of Lung Function |
|
Molecular Biomarkers in Tissue and Lining of Lungs Provide Another Technique for Lung Cancer Screening |
|
Lung Cancer Screening Via Video-Assisted Thoracic Surgery |
| Total News Item 850 | |
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.
http://jama.ama-assn.org